NCT05154955View on ClinicalTrials.gov

A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

March 19, 2024

Study Completion Date

March 19, 2024

Conditions
Submental Fat
Interventions
DRUG

10XB-101 Solution for Injection

One of the three concentrations of 10XB-101 will be evaluated against placebo for submental fat reduction.

DRUG

10XB-101 Vehicle Solution for Injection

This is the placebo control

Trial Locations (4)

60008

Site 04, Rolling Meadows

91436

Site 03, Encino

92122

Site 02, San Diego

92123

Site 01, San Diego

Sponsors

Lead Sponsor

10xBio, LLC
All Listed Sponsors
lead

10xBio, LLC

INDUSTRY